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Abstract
Compared to a conventional linear accelerator, the Cyberknife (CK) is a unique sys-
tem with respect to radiation protection shielding and the variety and number of
non-coplanar beams are two key components regarding this aspect. In this work, a
framework to assess the direction distribution and modulation factor (MF) of clini-
cally applied treatment beams of a CyberKnife M6 is developed. Database ﬁltering
options allow studying the inﬂuence of different parameters such as collimator
types, treatment sites or different bunker sizes. A distribution of monitor units (MU)
is generated by projecting treatment beams onto the walls, ﬂoor and ceiling of the
CyberKnife bunker. This distribution is found to be highly heterogeneous and
depending, among other parameters, on the bunker size. For our bunker design,
10%–13% of the MUs are delivered to the right and left wall, each. The ﬂoor
receives more than 64% of the applied MUs, while the wall behind the patient’s
head is not hit by primary treatment beams. Between 0% and 5% of the total MUs
are delivered to the wall at the patient’s feet. This number highly depends on the
treatment site, e.g., for extracranial patients no beams hit that wall. Collimator
choice was found to have minor inﬂuence on the distribution of MUs. On the other
hand, the MF depends on the collimator type as well as on the treatment site. The
MFs (delivered MU/prescribed dose) for all treatments, all MLC treatments, cranial
and extracranial treatments are 8.3, 6.4, 7.7, and 9.9 MU/cGy, respectively. The
developed framework allows assessing and monitoring important parameters regard-
ing radiation protection of a CK-M6 using the actually applied treatment beams.
Furthermore, it enables evaluating different clinical and constructional situations
using the ﬁltering options.
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1 | INTRODUCTION
In clinical practice of radiation oncology, staff members as well as
persons of the general public need to be protected from ionizing
radiation and dose limits according to locally relevant legal laws have
to be fulﬁlled. This leads to the typical task of a medical physicist to
optimize the design of bunkers such that radiation protection issues
are managed, while keeping the corresponding costs and resources
of the bunker construction as low as possible. This is a challenging
task for dedicated delivery systems such as the Cyberknife (CK) sys-
tem (Accuray Inc, Sunnyvale CA, USA). In general, the dose given to








= sum over all exposures i
_Di = dose rate due to exposure i
ti = time duration of exposure i
Based on eq. (1) one approach to realize practical radiation pro-
tection is the reduction of ti. Another possibility is to place attenuat-
ing material between the source of radiation and the person, e.g.,
build a bunker, which reduces the dose rate. This bunker shielding
problem can be separated into primary and secondary barriers.1 For
the CK system, the primary beam can point in almost any direction
such that almost everywhere a primary barrier is needed for radia-
tion protection purposes.2 Secondary beams are related to leakage
radiation as well as to scattered radiation and with respect to this,
the CK is not very much different from standard delivery systems
such as linear accelerators (linacs).
It is important for the motivation of this work that, a few years
ago, a new CK model (so-called M6 model) has been released, which
differs from the previous versions3 in geometrical and dose delivery
aspects. First, the CK-M6 version encompasses a more symmetric
arrangement between the delivery robot and the couch such that
the beam arrangements are also more symmetric than for previous
versions. Moreover, the CK-M6 is equipped with a multileaf collima-
tor (MLC) increasing the ﬂexibility and versatility.4 It is thus the aim
of this work to investigate whether shielding considerations for both,
primary and secondary radiation have to be revised when switching
from a conventional linac to the CK-M6. Furthermore, this work
assesses the impact of the novel MLC on the required radiation
shielding of the CK by analyzing clinically applied treatment beams.
2 | MATERIALS AND METHODS
2.A | Evaluated situation
For this study, clinical treatment plans delivered by a CK-M6 at our
center were analyzed. This robot-based stereotactic radiation ther-
apy system was initially equipped with a ﬁxed ﬁeld size interchange-
able cone collimators (Fix) and an Iris (Iris) collimator system5
allowing the collimation of the beam shaped into circles or dodeca-
gons, respectively. The twelve available diameters or
circumdiameters for these collimators range from 5 to 60 mm,
deﬁned at a source-to-axis distance (SAD) of 800 mm. Since 2015, a
third collimation device, the MLC is available in our clinic allowing to
deliver ﬁeld sizes up to 100 9 115 mm (again deﬁned at SAD of
800 mm). For the CK-M6, a treatment plan consists of several
beams, which originate from a discrete set of robot positions, called
nodes, and point toward different positions within the target vol-
ume.
For this study, we retrospectively analyzed a database of 364 CK
treatments performed at our center. Altogether, these patients
received 1115 treatment fractions, which lead to a total number of
166’125 applied beams. An overview of treated tumor sites and
used collimator types is provided in Table 1.
The primarily used bunker design in this work is illustrated by
Fig. 1. It resembles the footprint of our bunker and is referred by its
footprint size of 9.5 9 7.0 m2. For reasons of simplicity, the
entrance barrier was neglected in this study and dimensions in left
and right directions were adapted to be symmetrical. Figure 1 also
shows the position of the robot inside the bunker and the notations
for the different walls, the ﬂoor and the ceiling used throughout this
work.
2.B | Framework
The CK data management system stores information about all
applied beams into a database. This information can be extracted as
a log ﬁle in xml format. In a ﬁrst step, the newly developed frame-
work reads for each patient the prescribed dose and the log ﬁles
from all delivered patient treatments and creates a ﬁle containing
the following information for each delivered beam: robot position as
well as beam direction, number of delivered monitor units (MUs),
collimator system used, applied tracking mode, and ﬁeld size at SAD
800 mm. Note, that for the MLC the ﬁeld size is deﬁned as the area
that is not covered by the leaves. All those parameters, together
with the treatment site, which is mapped from a separate database,
are recorded and stored into the treatment list. This treatment list is
then purged from all sensitive information and serves as a com-
pletely anonymized repository of the clinically applied treatments. In
a second step, the CK bunker is deﬁned as a rectangular geometry
with freely selectable dimensions.





Head Lung Liver Prostate Spine Other All
Fix 156 0 0 1 6 0 163
Iris 99 18 15 14 10 24 180
MLC 6 1 7 6 0 1 21
All 261 19 22 21 16 25 364
Allocation of the included patients to the respective treatment site and
used collimator system.
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In order to extract and combine the available information, several
routines are implemented in Python (Python Software Foundation,
149 Hampton, NH, www.python.org), version 3.5. For all routines,
data may be ﬁltered according to collimator type or treatment site.
These routines allow an analysis of the mentioned parameters as
well as projecting the beams onto the inner surfaces of the consid-
ered bunker design by simply ray-tracing the beam on its central
beam axis.
2.C | Evaluated parameters
All beams included in the treatment list are weighted with the corre-
sponding MUs, projected onto the inner surface of the bunker (rep-
resented by 50 9 50 cm pixels) and the distribution of the applied
MUs are evaluated. This includes the MU distribution for each single
barrier as well as a top view of the bunker, resulting from integrating
all the applied MUs of the walls along the z-axis (as deﬁned in
Fig. 1). For further evaluations, the treatment list is ﬁltered in order
to investigate the inﬂuence of the different treatment sites and colli-
mator systems on previously described MU distributions for the bun-
ker barrier (cf. Table 1). To evaluate the inﬂuence of room size on
the MU distribution for different bunker geometries, different bun-
ker sizes are considered. In addition to the minimal allowed bunker
ﬂoor size of approximately 6.4 9 4.8 m2 and the recommended size
of 7.3 9 6.4 m2, also a rather small although ﬂexible bunker, and
large squared sized bunker with footprints of 6.4 9 6.4 m2 and
10.0 9 10.0 m2 are evaluated. The origin of the coordinate system
is placed at the center of the xy-plane, in a distance of 0.90 m
above the ﬂoor. The height of the bunker is kept constant at 3.90 m
for all bunker sizes.
Finally, histograms of the applied ﬁeld sizes of each beam are
created for the different collimator options of the CK-M6. For the
MLC ﬁelds, the diameter of a circle with the equivalent ﬁeld size as
the MLC opening is calculated.
Furthermore, the modulation factor (MF), as deﬁned by Purwar







The resulting MU distribution for all primary radiation beams in the
treatment list is visualized in Fig. 2 for the 9.5 9 7.0 m2 bunker.
From this ﬁgure, it can be concluded that the applied MUs are nei-
ther distributed homogenously between the different barriers nor is
the distribution homogenous on a single barrier itself. A more quan-
titative analysis is presented in Table 2, where the MU fractions for
the four walls, the ceiling and the ﬂoor are listed. Furthermore, the
results are separately shown for cranial as well as extracranial treat-
ments sites. While the number of beams hitting the wall at the
patient’s feet and the ceiling drop to zero for extracranial treatments,
about 13% more MUs are delivered to the ﬂoor, compared to the
cranial treatments. Table 2 further shows MU distributions as differ-
entiated by collimator system use.
As there are only few irradiations using the Fix collimator for
extracranial treatments and until now only few cases using the MLC
for cranial treatments, the following situations are compared: Fix col-
limator vs. Iris collimator for cranial treatments and Iris collimator vs.
MLC for extracranial treatments. The largest difference between col-
limators is, that using the MLC, about 5% more MUs are delivered
to the left or right wall instead of to the ﬂoor.
The ‘top-views’ in Fig. 3 show the overview of the MU distribu-
tion for all barriers simultaneously. In Fig. 3(a), the MU distribution
including all cases is shown. In contrast to the results for the CK-G4
by Yang and Feng,6 the distribution on the right wall and the left
wall is more symmetric for the CK-M6. Figures 3(b) and 3(c) show
the distribution for cranial and extracranial irradiations in order to
illustrate the differences due to the patient group. For both choices,
an asymmetry is visible in the left wall vs. right wall. However, as
shown in Table 2, the difference between the applied MUs to the
left and the right wall is smaller for the cranial than for the extracra-
nial irradiations: 0.3% vs. 1.7%. In order to determine whether the
F I G . 1 . CK bunker room coordinate
system. Sketch of the CK bunker room
with indicated dimensions and coordinate
system. The cross represents the origin of
the coordinate system. The blue circle and
the CK scheme indicate the position of the
robot inside the room. The blue rectangle
indicates the treatment couch. The labels
for the walls and the ceiling/ﬂoor will be
referenced to throughout this work.
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asymmetry in the extracranial distribution arises from the asymmet-
ric position of the targets in the body, the delivered MUs for the left
and right wall for different extracranial treatment sites are shown in
Table 3. The differences in the total MU delivered to the left or right
wall are more pronounced for the liver treatments than for lung,
prostate, and spine treatments.
The dependency of the MU distribution on the bunker size is
presented in Table 4. Compared to a large bunker, a smaller bunker
leads generally to larger MUs per pixel, as its inner surface area is
smaller. Furthermore, the MU distribution on the wall at the
F I G . 2 . MU distribution for all beams. Overview of the MU
distribution for all beams included in this study for our bunker. The
semi-transparent corners are the only locations that were hit by any
beams. The wall behind the patient’s head is not hit by any of the
applied beams. In gray, the patient lying in head-ﬁrst-supine position
is indicated.
TA B L E 2 Filtered MU distributions for the wall, ceiling, and ﬂoor.
Site All
Cranial Extracranial
Collimator All All Fix Iris All Iris MLC
Left 12.0% 12.3% 12.4% 12.1% 11.7% 11.5% 13.7%
Right 11.5% 12.7% 12.6% 12.7% 10.0% 9.6% 12.8%
Ceiling <0.1% 0.1% <0.1% 0.2% 0.0% 0.0% 0.0%
Floor 71.2% 65.4% 65.8% 64.9% 78.4% 78.9% 73.5%
Feet 5.3% 9.4% 9.1% 10.1% 0.0% 0.0% 0.0%
Head 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
MU distribution for the different walls, ceiling, and ﬂoor. Furthermore, ﬁlters regarding the treatment site and collimator system were applied.
F I G . 3 . Bunker top-view for different treatment sites. Top-view of the bunker, showing the MU distribution for the different walls,
integrated over their height. Left: Distribution for all beams. Middle: Cranial treatments. Right: Extracranial treatments. The blue circle and the
blue rectangle indicate the position of the robot as well as the treatment couch inside the room.
TA B L E 3 MU distribution for different treatment sites.
Left Right Difference
Liver 12.0% 5.5% 6.5%
Lung 10.7% 8.8% 1.9%
Prostate 15.2% 12.5% 2.7%
Spine 11.0% 10.8% 0.2%
MU distribution for the left and right walls for different extracranial
treatment sites.
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patient’s feet depends highly on the ratio of the bunker length from
the origin on (x-direction) and bunker width (y-direction). As the
bunker height is kept constant, the number of MUs hitting the ceil-
ing is mainly dominated by the distance between the origin and the
wall at the patient’s feet.
The analysis of the applied ﬁeld sizes, represented by histograms
of the ﬁeld diameters in Fig. 4, shows the continuous ﬁeld sizes
applied with the MLC versus the discrete ﬁeld sizes for the two
other collimation devices. As expected, Fix collimators are mainly
used for the smallest available ﬁeld sizes (5 and 7.5 mm diameter).
Furthermore, there are MLC ﬁelds applied with openings that are
beyond the largest possible Fix and Iris ﬁeld size (Fig. 4).
Finally, MFs of the treatment plans for the different collimation
devices and treatment sites are compared. While the mean MF for
the Fix collimator is the highest, the MLC shows the smallest MF
(Fig. 5). Although the extracranial treatments generally encompass
larger ﬁeld sizes, the mean MF is still higher than for cranial treat-
ments (Fig. 5). Investigating the MF of the different extracranial
treatment sites reveals that there are large differences between the
mean MF for spine treatments (15.4 MU/cGy), prostate treatments
(9.9 MU/cGy), liver treatments (7.2 MU/cGy), and lung treatments
(7.5 MU/cGy).
4 | DISCUSSION
A framework to evaluate important parameters regarding the radia-
tion protection considerations of a CK-M6 was developed. The
resulting MU-weighted direction distributions represent the current
situation at our Institute and are very heterogeneous for the differ-
ent barriers of the bunker. Whereas the left and right wall receive
between 10% and 13% of the MUs irrespective of the collimator
system or treatment site choice, the situation is different for the wall
at the patient’s feet. Cranial treatments result in a MU fraction of
about 5% delivered to that wall, while extracranial treatments do not
deliver direct beam there. This is explained analyzing the allowed
beam directions for those two treatment types. As the CK-M6 sys-
tem just allows beams with an elevation up to 22° from the horizon-
tal direction, the low number of MUs for ceiling is expected.
However, for cranial treatments some beams hit the corners of the
ceiling. The ﬂoor and the wall behind the patient’s head represent
TA B L E 4 MU distribution for the different bunker sizes.
6.4 3 4.8 m2 6.4 3 6.4 m2 7.3 3 6.4 m2 9.5 3 7.0 m2 10.0 3 10.0 m2
Left 13.8% 10.9% 11.2% 12.0% 9.2%
Right 13.2% 10.3% 10.7% 11.5% 8.7%
Ceiling 0.0% 0.0% 0.0% <1.0% <1.0%
Floor 64.8% 68.9% 69.3% 71.2% 73.4%
Feet 8.3% 10.0% 8.9% 5.3% 8.6%
Head 0.0% 0.0% 0.0% 0.0% 0.0%
MU distribution for the different walls, ceiling, and ﬂoor for different bunker sizes. The names in the header line correspond to the bunker footprints.
The expression ‘<1.0%’ means, that there are less than 1.0% but more the 0.0% of the MUs delivered.
F I G . 4 . Applied ﬁeld sizes for different collimators. Distribution of
the diameters for the applied ﬁelds, ﬁltered by the employed
collimator system. For the MLC, the diameter for a circle with the
equivalent ﬁeld size as the MLC opening is shown.
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the extreme values in this study, receiving 65%–79% and 0% of the
MUs, respectively. Even if the orientation of the CK-M6 and the
location of the adjacent rooms are already ﬁxed, the varying MU dis-
tribution over the barriers allows identifying suitable places to create
e.g., a cable duct.
The enhanced symmetry in the node distribution for the CK-M6
compared to the CK-G4 explains the observed differences in the
right and left wall MU distributions between the work of Yang and
Feng6 and this study. The anatomical location of target volumes
within the patient may further explain the differences in right and
left wall MU distributions in extra-cranial treatments.
Generally, the different collimator systems used had a minor
effect on the direction distribution, compared to the inﬂuence of dif-
ferent treatment sites.
While enlarging the area that has to be shielded, larger bunkers nat-
urally lead to a smaller number of MU/pixel. Furthermore, bunkers with
a nonsquared footprint lead to substantial changes in the MU ratio
between the left/right wall vs. the wall at the patient’s feet and ﬂoor.
F I G . 5 . Modulation factors for different collimators and treatment sites. Distribution of the MF per used collimator system and treatment
site. The MF is calculated by dividing the applied MUs per treatment plan by the prescribed dose [cGy].
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Regarding the secondary radiation, the mean MF for the Fix and
Iris collimators (8.6 and 8.3 MU/cGy) are larger than the mean MF
for the MLC of 6.4 MU/cGy. This is due to the segmented manner
of delivery as well as the larger ﬁeld sizes, which are offered by the
MLC and also used during the treatments (Fig. 5). In addition to the
collimator system choice, the treatment site has a major inﬂuence on
the MF.
So far, all clinically delivered beams at our institution are
included in the database. By always incorporating the most recent
treatments, it is possible to monitor the radiation protection issues
in almost real-time. Furthermore, the whole framework was devel-
oped in a two-step approach, in which the creation of the treatment
list removes any sensitive information. This allows easily comparing
data for different centers in future works.
5 | CONCLUSIONS
The developed framework allows analyzing and monitoring radiation
protection parameters for the present situation as well as ﬁltering
for collimators or treatment sites and exploring different bunker
sizes.
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